English
Leave Your Message
High-Quality Abciximab Biosimilar: (ITGA2B_ITGB3)- Research Grade

Antibody

High-Quality Abciximab Biosimilar: (ITGA2B_ITGB3)- Research Grade

  • Catalog number: ADT1005
  • Host species: CHO Cells
  • Application: ELISA, IHC, IF, IP, Flow Cyt, FuncS
  • Target: ITGA2B_ITGB3[Homo sapiens]

Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitionitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery.

Alpha Lifetech is proud to offer biosimilar antibodies product, Abciximab Biosimilar, designed to revolutionize the treatment of various research conditions. Our Abciximab Biosimila antibody product is manufactured using biotechnological processes, ensuring high purity, potency, and consistency in every batch. Alpha Lifetech adheres to stringent quality control measures throughout the production process, guaranteeing the safety and efficacy of our biosimilar antibody product. Choose Alpha Lifetech’s biosimilar antibody product for a reliable, effective, and cost-efficient treatment solution.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

Abciximab binds to the intact platelet GPIIb/IIIa receptor, which is a member of the integrin family of adhesion receptors and the major platelet surface receptor involved in platelet aggregation. This binding is thought to involve steric hindrance and/or conformational alterations which block access of large molecules to the receptor rather than direct interaction with the RGD (arginine-glycine-aspartic acid) binding site of GPIIb/IIIa. By binding to the vitronectin receptor (also known as the αvβ3 integrin), abciximab blocks effects mediated by this integrin which include cell adhesion. Furthermore, abciximab blocks Mac-1 receptor on monocytes and neutrophils thus inhibiting monocyte adhesion.

Product Specification

Catalog Number

ADT1005

Product Name

High-Quality Abciximab Biosimilar: (ITGA2B/ITGB3)- Research Grade

Chemical Formula

C6462H9964N1690O2049S48

Tags

biosimilar antibodies, biosimilar monoclonal antibodies, Abciximab Biosimilar, Abciximab, ITGA2B, ITGB3,143653-53-6

Clonity

Monoclonal

Host

CHO Cells

Target

ITGA2B_ITGB3[Homo sapiens]

CAS Number

143653-53-6

Molecular Weigh

145.65 KDa

Alias

c7E3

Isotype

Fab-G1 Kappa

Research area

Cardiovascular

Application

ELISA, IHC, IF, IP, Flow Cyt, FuncS

Size

1mg, 5mg

Concentration

batch dependent

Buffer

Supplied in PBS, PH7.5

Purity

>95% as determined by SDS-PAGE

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage. Avoid repeated freezing and thawing.

Metabolism

Most likely removed by opsonization via the reticuloendothelial system when bound to platelets, or by human antimurine antibody production. Excreted renally.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only.

FAQ

Leave Your Message